Trial
NCT03603288
Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Santhera Pharmaceuticals
Collaborators
—
Condition
Duchenne Muscular Dystrophy
Intervention
idebenone 150 mg film-coated tablets
Why stopped
Interim analysis concluded to futility of main study SIDEROS (SNT-III-012)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-03